Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases

The treatment of recurrent hepatocellular carcinoma (HCC) after liver transplantation is difficult due to the lack of effective treatment options. The available evidence on the emerging immunotherapy in liver transplantation is based on anecdotal experiences and requires additional investigations. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Jarroudi, Ouissam, Ulusakarya, Ayhan, Almohamad, Wathek, Afqir, Said, Morere, Jean-Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586420/
https://www.ncbi.nlm.nih.gov/pubmed/33133796
http://dx.doi.org/10.7759/cureus.11150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586420/
https://www.ncbi.nlm.nih.gov/pubmed/33133796
http://dx.doi.org/10.7759/cureus.11150

Ejemplares similares